| Rosenblum Mark J |
Exec VP Finance, CFO |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2025-11-20 |
$0.80 |
0.0% |
20,000
|
$16,000 |
| Rosenblum Mark J |
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-05-31 |
$540.00 |
-99.7% |
9
|
$5,040 |
| Rosenblum Mark J |
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2022-03-03 |
$1173.00 |
-99.9% |
25
|
$29,812 |
| Rosenblum Mark J |
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-08-17 |
$3000.00 |
-99.9% |
2
|
$5,000 |
| Rosenblum Mark J |
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-19 |
$2850.00 |
-99.9% |
1
|
$1,900 |
| Rosenblum Mark J |
Exec VP Finance |
Salarius Pharmaceuticals, Inc. (SLRX)
|
2020-02-13 |
$2577.00 |
-99.9% |
2
|
$4,295 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-74.1% |
$-45,987 |
$62,047 |